Topics

Lynparza extends progression-free survival in first-line advanced #OvarianCancer, with or without BRCA mutations http://bit.ly/3040DfI  #pharma #Cancerpic.twitter.com/UI8fDmqJcr

14:30 EDT 14 Aug 2019 | Pharmafile

Lynparza extends progression-free survival in first-line advanced , with or without BRCA mutations http://bit.ly/3040DfI 

Original Article: Lynparza extends progression-free survival in first-line advanced #OvarianCancer, with or without BRCA mutations http://bit.ly/3040DfI  #pharma #Cancerpic.twitter.com/UI8fDmqJcr

NEXT ARTICLE

More From BioPortfolio on "Lynparza extends progression-free survival in first-line advanced #OvarianCancer, with or without BRCA mutations http://bit.ly/3040DfI  #pharma #Cancerpic.twitter.com/UI8fDmqJcr"

Quick Search